Yibin Kang is a Professor of Molecular Biology at Princeton University and a Member of the Cancer Institute of New Jersey. He graduated with a bachelor’s degree from Fudan University in Shanghai in 1995. After completing his graduate study at Duke in 2000, Dr. Kang became an Irvington Institute postdoctoral fellow with Dr. Joan Massagué at the Memorial Sloan-Kettering Cancer Center and pioneered a functional genomic approach to elucidate the mechanism of breast cancer metastasis. Dr. Kang joined the faculty of Princeton University as an Assistant Professor of Molecular Biology in the fall of 2004. He was promoted to Associate Professor with tenure in 2010 and to Professor in 2012. Dr. Kang’s research focuses on the molecular mechanisms of breast cancer metastasis. His laboratory applies a multidisciplinary approach to analyze the molecular basis of cancer metastasis, combining molecular biology and genomics tools with animal models and advanced in vivo imaging technologies. Dr. Kang has published over 70 original articles in leading journals including Cell, Cancer Cell, and Nature Medicine. His work has discovered new genes that promote recurrence, metastasis and chemoresistance, delineated tumor-stromal interactions that are essential for metastatic growth, and identified novel regulators of mammary gland stem cells. Dr. Kang's outstanding achievements have been recognized by many prestigious awards, including a Department of Defense Era of Hope Scholar Award and in 2011 The Vicek Prize for Creative Promise in Biomedical Sciences, a prestigious award honoring foreign-born artists and scientists who have demonstrated exceptional creativity and originality in the early stages of their careers in the United States.
Abstracts this author is presenting: